                         SEQUENCE LISTING

<110>  Georgia State University Research Foundation, Inc.
       Basler, Christopher  F
       Wang, Lin  F
       Tufariello, JoAnn M.
 
<120>  VIRUS-LIKE PARTICLES AND USES THEREOF

<130>  056777-1179349 (002WO1)

<150>  US 62/821,744
<151>  2019-03-21

<160>  7     

<170>  PatentIn version 3.5

<210>  1
<211>  139
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic construct

<400>  1

Thr Pro Thr Val Ala Pro Pro Ala Pro Val Tyr Arg Asp His Ser Glu 
1               5                   10                  15      


Lys Lys Glu Leu Pro Gln Asp Glu Gln Gln Asp Gln Asp His Thr Gln 
            20                  25                  30          


Glu Ala Arg Asn Gln Asp Ser Asp Asn Thr Gln Ser Glu His Ser Phe 
        35                  40                  45              


Glu Glu Met Tyr Arg His Ile Leu Arg Ser Gln Gly Pro Phe Asp Ala 
    50                  55                  60                  


Val Leu Tyr Tyr His Met Met Lys Asp Glu Pro Val Val Phe Ser Thr 
65                  70                  75                  80  


Ser Asp Gly Lys Glu Tyr Thr Tyr Pro Asp Ser Leu Glu Glu Glu Tyr 
                85                  90                  95      


Pro Pro Trp Leu Thr Glu Lys Glu Ala Met Asn Glu Glu Asn Arg Phe 
            100                 105                 110         


Val Thr Leu Asp Gly Gln Gln Phe Tyr Trp Pro Val Met Asn His Lys 
        115                 120                 125             


Asn Lys Phe Met Ala Ile Leu Gln His His Gln 
    130                 135                 


<210>  2
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic construct

<400>  2

Ser Gly Gly Ser Gly Gly Ser Gly 
1               5               


<210>  3
<211>  210
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic construct

<400>  3

Met Thr Thr Glu Gln Arg Arg Ser Leu Gln Ala Phe Gln Asp Tyr Ile 
1               5                   10                  15      


Arg Lys Thr Leu Asp Pro Thr Tyr Ile Leu Ser Tyr Met Ala Pro Trp 
            20                  25                  30          


Phe Arg Glu Glu Glu Val Gln Tyr Ile Gln Ala Glu Lys Asn Asn Lys 
        35                  40                  45              


Gly Pro Met Glu Ala Ala Thr Leu Phe Leu Lys Phe Leu Leu Glu Leu 
    50                  55                  60                  


Gln Glu Glu Gly Trp Phe Arg Gly Phe Leu Asp Ala Leu Asp His Ala 
65                  70                  75                  80  


Gly Tyr Ser Gly Leu Tyr Glu Ala Ile Glu Ser Trp Asp Phe Lys Lys 
                85                  90                  95      


Ile Glu Lys Leu Glu Glu Tyr Arg Leu Leu Leu Lys Arg Leu Gln Pro 
            100                 105                 110         


Glu Phe Lys Thr Arg Ile Ile Pro Thr Asp Ile Ile Ser Asp Leu Ser 
        115                 120                 125             


Glu Cys Leu Ile Asn Gln Glu Cys Glu Glu Ile Leu Gln Ile Cys Ser 
    130                 135                 140                 


Thr Lys Gly Met Met Ala Gly Ala Glu Lys Leu Val Glu Cys Leu Leu 
145                 150                 155                 160 


Arg Ser Asp Lys Glu Asn Trp Pro Lys Thr Leu Lys Leu Ala Leu Glu 
                165                 170                 175     


Lys Glu Arg Asn Lys Phe Ser Glu Leu Trp Ile Val Glu Lys Gly Ile 
            180                 185                 190         


Lys Asp Val Glu Thr Glu Asp Leu Glu Asp Lys Met Glu Thr Ser Asp 
        195                 200                 205             


Ile Gln 
    210 


<210>  4
<211>  201
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic construct

<400>  4

Met Ser Asn Gly Tyr Ser Thr Asp Glu Asn Phe Arg Tyr Leu Ile Ser 
1               5                   10                  15      


Cys Phe Arg Ala Arg Val Lys Met Tyr Ile Gln Val Glu Pro Val Leu 
            20                  25                  30          


Asp Tyr Leu Thr Phe Leu Pro Ala Glu Val Lys Glu Gln Ile Gln Arg 
        35                  40                  45              


Thr Val Ala Thr Ser Gly Asn Met Gln Ala Val Glu Leu Leu Leu Ser 
    50                  55                  60                  


Thr Leu Glu Lys Gly Val Trp His Leu Gly Trp Thr Arg Glu Phe Val 
65                  70                  75                  80  


Glu Ala Leu Arg Arg Thr Gly Ser Pro Leu Ala Ala Arg Tyr Met Asn 
                85                  90                  95      


Pro Glu Leu Thr Asp Leu Pro Ser Pro Ser Phe Glu Asn Ala His Asp 
            100                 105                 110         


Glu Tyr Leu Gln Leu Leu Asn Leu Leu Gln Pro Thr Leu Val Asp Lys 
        115                 120                 125             


Leu Leu Val Arg Asp Val Leu Asp Lys Cys Met Glu Glu Glu Leu Leu 
    130                 135                 140                 


Thr Ile Glu Asp Arg Asn Arg Ile Ala Ala Ala Glu Asn Asn Gly Asn 
145                 150                 155                 160 


Glu Ser Gly Val Arg Glu Leu Leu Lys Arg Ile Val Gln Lys Glu Asn 
                165                 170                 175     


Trp Phe Ser Ala Phe Leu Asn Val Leu Arg Gln Thr Gly Asn Asn Glu 
            180                 185                 190         


Leu Val Gln Glu Leu Thr Gly Ser Asp 
        195                 200     


<210>  5
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic construct

<400>  5

Leu Tyr Asp Arg Leu Ala Ser Thr Val 
1               5                   


<210>  6
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic construct

<400>  6

Tyr Phe Thr Phe Asp Leu Thr Ala Leu Lys 
1               5                   10  


<210>  7
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic construct

<400>  7

Pro Glu Tyr Met Glu Ala Ile Tyr Pro Val Arg Ser Asn Ser Thr 
1               5                   10                  15  


